ICON Public Limited Company (ICLR) Stock

ICON Public Limited Company, based in Dublin, Ireland, is a premier clinical research organization renowned for its comprehensive outsourced development and commercialization services across Ireland, Europe, the United States, and globally. Specializing in the strategic management and analysis of programs throughout the clinical development lifecycle, ICON supports various stages from compound selection through Phase I-IV clinical studies. Its extensive portfolio includes clinical development services encompassing early development, patient recruitment, strategic analytics, and late-phase research, along with robust data and technology solutions.

ICON excels in providing a wide array of clinical research services such as medical imaging, laboratory services, project management, and site monitoring. The company's expertise extends to critical areas like data management, biostatistics, medical writing, pharmacovigilance, and regulatory strategies, ensuring comprehensive support for pharmaceutical, biotechnology, and medical device industries. Moreover, ICON engages in consulting and advisory services, further enhancing its role as a strategic partner in advancing healthcare innovations.

Founded in 1990, ICON has established itself as a pivotal player in the clinical research field, delivering excellence in endpoint adjudication, medical affairs, interactive response technologies, clinical supplies management, and medical communications. With a commitment to quality and innovation, ICON continues to drive advancements in clinical trial management, supporting clients ranging from industry leaders to government and public health organizations worldwide.